Tom Walley
Dados Biográficos
| ID | 1740798 |
|---|---|
| NOME | Tom Walley |
| PRENOMES | Tom |
| SOBRENOME | Walley |
| ASSINATURA | WALLEY T |
| AFILIAÇÕES | University of Liverpool |
| VERIFICADO | Não |
| TOTAL DE OBRAS | 10 |
| TOTAL DE CITAÇÕES | 11 |
| TOTAL COMO AUTOR | 10 |
| TOTAL COMO EDITOR | 0 |
| PRIMEIRO ANO DE PUBLICAÇÃO | 1997 |
| ANO MAIS RECENTE DE PUBLICAÇÃO | 2016 |
| ÍNDICE H | 2 |
Patients' expectations of medicines – a review and qualitative synthesis
A randomised controlled trial of extended brief intervention for alcohol dependent patients in an acute hospital setting (Adpac)
ISRCTN: ISRCTN78062794
Seral antibiotics at home in cystic fibrosis
Pharmaceutical Pricing in Europe
Rising healthcare costs, particularly pharmaceutical expenditures, have led to the implementation of several pharmaceutical pricing regulations and policies throughout the world. This paper undertakes a critical review of current policies, along with a discussion of alternatives for both on-patent and off-patent drug pricing mechanisms. Traditional direct and indirect price controls have failed to balance the objectives of efficiency and equity. …
New drug prescribing by hospital doctors
A qualitative study of GPs' and PCO stakeholders' views on the importance and influence of cost on prescribing
Involving consumers in a needs‐led research programme
Objectives To describe the methods used for involving consumers in a needs‐led health research programme, and to discuss facilitators, barriers and goals. Design In a short action research pilot study, we involved consumers in all stages of the Health Technology Assessment (HTA) Programme: identifying and prioritizing research topics; commissioning and reporting research; and communicating openly about the programme. We drew on the experience of …
Investigating Consumer Perspectives on Evaluating Health Technologies
In a short pilot study we systematically involved healthcare consumers in identifying research topics, and prioritizing, commissioning and reporting evaluations of health technologies. We analysed records of consumers' suggestions for their content and, wherever possible, compared them with suggestions from academics and staff of the UK National Health Service. Consumers tended to highlight issues about patients' views, social contexts, informati…
Managing the entry of new medicines in the National Health Service
For the most part, the management of new medicines in the NHS has hitherto been a matter for local discretion. The result is that access to medicines is often determined by where a patient lives, as opposed to some nationally agreed clinical criteria. This "postcode prescribing" has led to widespread variations in access to medicines and concerns about the resulting inequalities. Primary care groups and trusts are expected to reduce variations in…
Economic evaluation under managed competition
New drug prescribing by hospital doctors
Pharmaceutical Pricing in Europe
Rising healthcare costs, particularly pharmaceutical expenditures, have led to the implementation of several pharmaceutical pricing regulations and policies throughout the world. This paper undertakes a critical review of current policies, along with a discussion of alternatives for both on-patent and off-patent drug pricing mechanisms. Traditional direct and indirect price controls have failed to balance the objectives of efficiency and equity. …
Economic evaluation under managed competition
A qualitative study of GPs' and PCO stakeholders' views on the importance and influence of cost on prescribing
Economic evaluation under managed competition
Involving consumers in a needs‐led research programme
Objectives To describe the methods used for involving consumers in a needs‐led health research programme, and to discuss facilitators, barriers and goals. Design In a short action research pilot study, we involved consumers in all stages of the Health Technology Assessment (HTA) Programme: identifying and prioritizing research topics; commissioning and reporting research; and communicating openly about the programme. We drew on the experience of …
Investigating Consumer Perspectives on Evaluating Health Technologies
In a short pilot study we systematically involved healthcare consumers in identifying research topics, and prioritizing, commissioning and reporting evaluations of health technologies. We analysed records of consumers' suggestions for their content and, wherever possible, compared them with suggestions from academics and staff of the UK National Health Service. Consumers tended to highlight issues about patients' views, social contexts, informati…
Managing the entry of new medicines in the National Health Service
For the most part, the management of new medicines in the NHS has hitherto been a matter for local discretion. The result is that access to medicines is often determined by where a patient lives, as opposed to some nationally agreed clinical criteria. This "postcode prescribing" has led to widespread variations in access to medicines and concerns about the resulting inequalities. Primary care groups and trusts are expected to reduce variations in…
A qualitative study of GPs' and PCO stakeholders' views on the importance and influence of cost on prescribing
Pharmaceutical Pricing in Europe
Rising healthcare costs, particularly pharmaceutical expenditures, have led to the implementation of several pharmaceutical pricing regulations and policies throughout the world. This paper undertakes a critical review of current policies, along with a discussion of alternatives for both on-patent and off-patent drug pricing mechanisms. Traditional direct and indirect price controls have failed to balance the objectives of efficiency and equity. …
New drug prescribing by hospital doctors
Seral antibiotics at home in cystic fibrosis
A randomised controlled trial of extended brief intervention for alcohol dependent patients in an acute hospital setting (Adpac)
ISRCTN: ISRCTN78062794
Patients' expectations of medicines – a review and qualitative synthesis
Medicine (7 obras) · Business (6 obras) · Health Systems, Economic Evaluations, Quality of Life (5 obras) · Political science (5 obras) · Health care (4 obras) · Economics (3 obras) · Family medicine (3 obras) · Nursing (3 obras) · Psychology (3 obras) · Public economics (3 obras)